Stay updated with breaking news from More Cures Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Six months into the fiscal year, Congress has finally passed FY2024 appropriations. It was a painstaking process, which many expected to include policy victories that both sides could celebrate.
Prescription drug costs have skyrocketed and become a growing financial burden, but the White House’s drug price controls will not solve the drug affordability crisis. However, they will threaten the development of future cures and harm patient health.
Republican 2022 midterms underperformance is not expected to dampen Congressional Pharmacy Benefit Manager PBM reform. Issue remains at forefront of healthcare pricing debate. No longer seen as Republican-driven effort due to Inflation Reduction Act IRA drug pricing reforms.
The 2022 midterms have concluded, but the Republican underperformance is not expected to dampen Congressional enthusiasm for Pharmacy Benefit Manager (PBM) reform. The issue remains at...
Montana Sens. Jon Tester and Steve Daines advanced their own policy positions through amendments in the Inflation Reduction Act debate.